CD8A and neoplasm: Thus, in IKE-treated TIPE2−/− LLC-bearing mice, increasing the accumulation of immunostimulatory MDSCs can promote effector CD4+ and CD8+ T cells to infiltrate into the tumor tissues, but restrain the immunosuppressive Tregs.